PAX5 and acute lymphoblastic leukemia: Intriguingly, B-ALL with ZNF384 rearrangement, DUX4 rearrangement or PAX5 p.P80R may show monocytic differentiation following therapy and even at diagnosis [27, 28], broadening concepts of the plasticity of leukemic lineages.